bioAffinity Technologies Announces Formation of Scientific and Medical Advisory Board; M. Patricia Rivera, MD, Joins Board as Chair
12. März 2019 11:00 ET
|
bioAffinity Technologies, Inc.
SAN ANTONIO, March 12, 2019 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held biotech company, today announced the formation of a Scientific and Medical Advisory (SMA) Board to provide...
bioAffinity Technologies Selected as Finalist for Cancer Innovation Award
06. März 2019 11:00 ET
|
bioAffinity Technologies, Inc.
SAN ANTONIO, March 06, 2019 (GLOBE NEWSWIRE) -- Healthcare innovators Lyfebulb and Helsinn selected bioAffinity Technologies, a privately held biotech company developing diagnostics and therapeutics...
bioAffinity Technologies Announces Award of Canadian Patent
04. Februar 2019 12:25 ET
|
bioAffinity Technologies, Inc.
SAN ANTONIO, Feb. 04, 2019 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held biotech company, announced that the Canadian Intellectual Property Office has awarded a patent expanding the...
bioAffinity Licenses CyPath® Lung to Precision Pathology Services
10. Oktober 2018 12:00 ET
|
bioAffinity Technologies, Inc.
SAN ANTONIO, Oct. 10, 2018 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held biotech company, today announced a licensing agreement with Precision Pathology Services for the continued...
bioAffinity Technologies Welcomes Mohsin Y. Meghji to Board of Directors
31. Juli 2018 11:00 ET
|
bioAffinity Technologies, Inc.
SAN ANTONIO, July 31, 2018 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held biomedical company advancing breakthrough cancer diagnostics and therapeutics, is pleased to welcome Mohsin...
bioAffinity Technologies Welcomes Peter S. Knight to Board of Directors
14. Mai 2018 10:00 ET
|
bioAffinity Technologies, Inc.
SAN ANTONIO, May 14, 2018 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held biomedical company advancing breakthrough cancer diagnostics and therapeutics, is pleased to welcome Peter S....
bioAffinity Technologies Joins Early Detection Research Network
01. März 2018 11:00 ET
|
bioAffinity Technologies, Inc.
SAN ANTONIO, March 01, 2018 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held cancer diagnostics company, today announced it has been approved for membership in the Early Detection...
bioAffinity Technologies Welcomes New Board Members
29. November 2017 11:00 ET
|
bioAffinity Technologies, Inc.
SAN ANTONIO, Nov. 29, 2017 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held cancer diagnostics and therapeutics company, today announced the appointments of Stephen Squinto, Ph.D., and...
City of San Antonio Invests in bioAffinity Technologies
09. März 2017 19:02 ET
|
bioAffinity Technologies, Inc.
SAN ANTONIO, March 09, 2017 (GLOBE NEWSWIRE) -- The San Antonio City Council today authorized the San Antonio Economic Development Corporation (SAEDC) to invest in locally based bioAffinity...
bioAffinity Technologies Announces Award of Hong Kong Patent
15. November 2016 09:00 ET
|
bioAffinity Technologies, Inc.
SAN ANTONIO, Nov. 15, 2016 (GLOBE NEWSWIRE) -- bioAffinity Technologies announced that the government of the Hong Kong Special Administrative Region has awarded a Certificate of Grant of Standard...